Cagrilintide B

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

ObesityOverweight

Phase 1

A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

CompletedNCT06719011

Novo Nordisk A/SObesity, Overweight

Start: 2024-12-03End: 2026-07-20Updated: 2026-08-25

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

CompletedNCT07605052

Novo Nordisk A/SObesity, Overweight

Start: 2026-05-20End: 2026-08-19Updated: 2026-09-04